|
|
|
|
|
Irinotecan HCL Trihydrate |
|
Irinotecan, anti-cancer, 136572-09-3 |
|
136572-09-3 |
|
Characteristics Off white to light crystalline powder Specific rotation +63¡Æ¢¦+69¡Æ Total unknown substances ¡Â0.50% Maximal single substances ¡Â0.100% Loss on drying 7.00%¢¦9.00% Residue on ignition ¡Â0.20% Heavy metals ¡Â10ppm Endotoxin ¡Â0.3E¥ì/mg Assay ¡Ã99.0% Standard: Enterprise Standard.
|
|
powder |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|